"Expecting development and CEO being upbeat are not really facts are they, was wanting to know some real facts."
So do I shnan - how did you manage to buy OBJ shares between 17:42pm and 19:59pm on Friday evening?
Steini was courteous enough to reply with some facts but you would need to do some research to better understand the significance of what he offered - and I say this with sincerity as I know that information probably didn't mean alot to you if you were not already aware of anticipated joint development negotiations and a very conservative MD who has never before been this "upbeat"
Bluebush and Surges have both offered you an excellent summary imo, but I would also echo the same advise in closing by Bluebush - to do a due diligence. I would recommend the last two Annual Reports and AGM Corporate Presentation along with the following links as a good starting point. Imo.
So I ask, What happens to OBJ if WHEN someone was to buy licenses this technology!
OBJ gets re-rated ;) ___
Patent applications should be organized and drafted with a long-term objective that carefully considers the multiple possibilities, and opportunities, of field-of-use licensing. This is particularly the case in the biotechnology and pharmaceutical disciplines, as inventions can have multiple applications that are sometimes impossible to foresee.
Technology managers must, therefore, focus strategically, not only on the basic idea of an invention but broadly, in order to consider the various ways such an invention might be put into more widespread and more profitable use.
Therefore, the more details, examples and alternatives that are thought through and then disclosed in the patent application, the greater the opportunity for future divisional or continuation applications, as well as future claims that can be exclusively (field-of-use) licensed.
By making all of OBJ's licenses, in effect, field-of-use licenses, the company retains the ability to take a possible future use and license it to someone else, maximizing the benefits of the inventions and generating higher royalties for OBJ.
Field-of-use licensing will provide OBJ with greater control over the use of its intellectual property, while maximizing the use and value of the technology.
When is field-of-use licensing worth the extra effort?
When more than one company is needed to fully develop a technology’s potential, when different licensees are needed to address different markets, or when field-of-use licensing has the potential to significantly increase the financial return from a technology. In all of these situations, field-of-use licensing can produce better results for everyone involved.
Sourced from IP Handbook - (* I filled in OBJ's name) ___
27 September 2011: OBJ - 2011 Annual Report
Intellectual Property Over the period, the Company has undertaken significant expansion to its IP and Patent portfolios with the lodgement of 6 additional "Field of Use" patent applications covering the major commercial areas of interest to OBJ's partner companies and the progression of its foundation patents through to final examination in both the USA and Europe. These programs are designed to provide OBJ with broad exclusivity across key markets and to allow efficient and effective licensing across key market sectors. ___
03 November 2011: OBJ - Granting of US Patent for Dermaportation Technology
OBJ Limited today announced that it has received the Dermaportation Patent issued by the US Patent office, following the allowance of claims announced on 23 August 2011.
The granting of the patent enhances the potential commercial value of the Company’s powered Dermaportation technology as it allows the Company to offer various market licensing options to potential partners in key market sectors. ___
Hi Boydy,
"Mounting evidence right around the world IMO is slowley building and will eventually end in an avalanche of change in the way humans interact with drug delivery, human health and cosmetic delivery. All we have to do is look at OBJ's technologies and one can't but feel excited and optomistic about the future of our company"
We are on exactly the same page!
OBJ Price at posting:
2.3¢ Sentiment: LT Buy Disclosure: Held
(20min delay)